Autoimmune disease-associated histamine receptor H1 alleles exhibit differential protein trafficking and cell surface expression

Journal of Immunology

Volumn 180, Issue 11, 2008, Pages 7471-7479

  Noubade, Rajkumar ^a   Saligrama, Naresha ^a   Spach, Karen ^a   Del Rio, Roxana ^a   Blankenhorn, Elizabeth P ^b   Kantidakis, Theodoros ^c   Milligan, Graeme ^c   Rincon, Mercedes ^a   Teuscher, Cory ^a,d  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE H1 RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT;

ALLELE; ALLERGIC ENCEPHALOMYELITIS; ARTICLE; AUTOIMMUNE DISEASE; CELL SURFACE; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DNA POLYMORPHISM; ENDOPLASMIC RETICULUM; HAPLOTYPE; NONHUMAN; ORCHITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; T LYMPHOCYTE; ANIMAL; C57BL MOUSE; CELL LINE; CELL MEMBRANE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; MALE; METABOLISM; MOUSE; PROTEIN TRANSPORT; TRANSGENIC MOUSE;

ALLELES; ANIMALS; AUTOIMMUNE DISEASES; CELL LINE; CELL MEMBRANE; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENDOPLASMIC RETICULUM; GENETIC PREDISPOSITION TO DISEASE; GTP-BINDING PROTEIN ALPHA SUBUNITS; HAPLOTYPES; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; ORCHITIS; POLYMORPHISM, GENETIC; PROTEIN TRANSPORT; RECEPTORS, HISTAMINE H1; T-LYMPHOCYTES;

EID: 47249134977     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.11.7471     Document Type: Article

References (36)

1. Greenstein, J. I. 2007. Current concepts of the cellular and molecular pathophys-iology of multiple sclerosis. Dev. Neurobiol. 67: 1248-1265.
2. Hafler, D. A., J. M. Slavik, D. E. Anderson, K. C. C. OConnor, P. De Jager, and C. Baecher-Allan. 2005. Multiple sclerosis. Immunol. Rev. 204: 208-231.
3. Kantarci, O., and D. Wingerchuk. 2006. Epidemiology and natural history of multiple sclerosis: new insights. Curr. Opin. Neurol. 19: 248-254.
4. Gold, R., H. P. Hartung, and K. V. Toyka. 2000. Animal models for autoimmune demyelinating disorders of the nervous system. Mol. Med. Today 6: 88-91.
5. Kuchroo, V. K., A. C. Anderson, H. Waldner, M. Munder, E. Bettelli. and L. B. Nicholson. 2002. T cell response in experimental autoimmune encephalo-myelitis (EAE): role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire. Annu. Rev. Immunol. 20: 101-123
6. Andersson, A., and J. Karlsson. 2004. Genetics of experimental autoimmune encephalomyelilis in the mouse. Arch. Immunol. Ther. Exp. 52: 316-325.
7. Ma, R. Z., J. Gao, N. D. Meeker, P. D. Fillmore, K. S. Tung, T. Watanabe, J. F. Zachary, H. Offner, E. P. Blankenhom, and C. Teuscher. 2002. Identification of Bphs, an autoimmune disease locus, as histamine receptor H1. Science 297: 620-623.
8. Linthicum, D. S., and J. A. Frelinger. 1982. Acute autoimmune encephalomyelitis in mice. II. Susceptibility is controlled by the combination of H-2 and histamine sensitization genes. J. Exp. Med. 156: 31-40.
9. Teuscher, C. 1985. Experimental allergic orchitis in mice. II. Association of disease susceptibility to the locus controlling Bordetella perlussis-induced sensitivity to histamine. lmmunogenetics 22: 417-425.
10. Parsons, M. E., and C. R. Ganellin. 2006. Histamine and its receptors. Br. J. Pharmacol. 147(Suppl. I): S127-S135.
11. Noubade, R., G. Milligan, J. F. Zachary, E. P. Blankenhom, R. del Rio, M. Rincon, and C. Teuscher. 2007. Histamine receptor II1 is required for TCR-mediated p38 MAP kinase activation and IFN-γ production. J. Clin. Invest. 117: 3507-3518.
12. Tan, C. M., A. E. Brady, H. H. Nickols, Q. Wang, and L. E. Limbird. 2004. Membrane trafficking of G protein-coupled receptors. Annu. Rev. Pharmacol. Toxicol. 44: 559-609.
13. Banu, Y., and T. Watanabe. 1999. Augmentation of antigen receptor-mediated responses by histamine H1 receptor signaling. J. Exp. Med. 189: 673-682.
14. Wildin, R. S., A. M. Garvin, S. Pawar, D. B. Lewis, K. M. Abraham, K. A. Forbush, S. F. Ziegler, J. M. Allen, and R. M. Perlmutter. 1991. Developmental regulation of Ick gene expression in T lymphocytes. J. Exp. Med. 173: 383-393.
15. Bakker, R. A., G. Dees, J. J. Carrillo, R. G. Booth, J. F. Lopcz-Gimenez, G. Milligan, P. G. Strange, and R. Leurs. 2004. Domain swapping in the human histamine HI receptor. J. Pharmacol. Exp. Ther. 311: 131-138.
16. Mitchell, F. M., I. Mullaney, P. P. Godfrey, S. J. Arkinstall, M. J. Wakelam, and G. Milligan. 1991. Widespread distribution of Gqα/G11α detected immunologi-cally by an antipeptide antiserum directed against the predicted C-terminal de-capeptide. FEBS Lett. 287: 171-174.
17. Butterfield, R. J., J. D. Sudweeks, E. P. Blankenhom, R. Komgold, J. C. Marini, J. A. Todd, R. J. Roper, and C. Teuscher. 1998. New genetic loci that control susceptibility and symptoms of experimental allergic encephalomyelitis in inbred mice. J. Immunol. 161: 1860-1867.
18. Teuscher, C, R. Noubade, K. Spach, B. McElvany, J. Y. Bunn, P. D. Fillmore, J. F. Zachary, and E. P. Blankenhom. 2006. Evidence that the Y chromosome influences autoimmune disease in male and female mice. Proc. Natl. Acad. Sci. USA 103: 8024-8029.
19. Furuzawa-Carballeda, J., M. I. Vargas-Rojas, and A. R. Cabral. 2007. Autoimmune inflammation from the Thl7 perspective. Autoimmun. Rev. 6: 169-175.
20. Tao, Y. X. 2006. Inactivating mutations of G protein-coupled receptors and diseases: structure-function insights and therapeutic implications. Pharmacol. Ther. 111:949-973.
21. Sewell, W. A., J. J. Munoz, and M. A. Vadas. 1983. Enhancement of the intensity, persistence, and passive transfer of delayed-type hypersensitivity lesions by pertussigen in mice. J. Exp. Med. 157: 2087-2096.
22. Sewell, W. A., J. J. Munoz, R. Scollay, and M. A. Vadas. 1984. Studies on the mechanism of the enhancement of delayed-type hypersensitivity by pertussigen. J. Immunol. 133: 1716-1722.
23. Sewell, W. A., P. A. de Moerloose, J. A. Hamilton, J. \V. Schrader, I. R. Mackay, and M. A. Vadas. 1987. Potentiation of delayed-type hypersensitivity by pertussigen or cyclophosphamide with release of different Iymphokines. Immunology 61: 483-488.
24. Gao, J. F., S. B. Call, P. D. Fillmore, T. Watanabe, N. D. Meeker, and C. Teuscher. 2003. Analysis of the role of Bphs/Hrhl in the genetic control of responsiveness to pertussis toxin. Infect. Immun. 71: 1281-1287.
25. Chen, X., O. M. Howard, and J. J. Oppenheim. 2007. Pertussis toxin by inducing IL-6 promotes the generation of IL-17-producing CD4 cells. J. Immunol. 178: 6123-6129.
26. Triggiani, M., M. Gentile, A. Secondo, F. Granata, A. Oriente, M. Taglialatela, L. Annunziato, and G. Marone. 2001. Histamine induces exocytosis and IL-6 production from human lung macrophages through interaction with H1 receptors. J. Immunol. 166: 4083-4091.
27. Spiegel, A. M., and L. S. Weinstein. 2004. Inherited diseases involving G proteins and G protein-coupled receptors. Annu. Rev. Med. 55: 27-39.
28. Duvernay, M. T., C. M. Filipeanu, and G. Wu. 2005. The regulatory mechanisms of export trafficking of G protein-coupled receptors. Cell. Signal. 17: 1457-1465.
29. Sparks, A. B., N. G. Hoffman, S. J. McConnell, D. M. Fowlkes, and B. K. Kay. 1996. Cloning of ligand targets: systematic isolation of SH3 domain-containing proteins. Nat. Biotechnol. 14: 741-744.
30. Oldenhof, J., R. Vickery, M. Anafi, J. Oak, A. Ray, O. Schools, T. Pawson, M. von Zastrow, and H. H. Van Tol 1998. SH3 binding domains in (he dopamine D4 receptor. Biochemistry 37: 15726-15736.
31. Shieh, B. H., M. A. Stamnes, S. Seavello, G. L. Harris, and C. S. Zuker. 1989. The ninaA gene required for visual transduction in Drosophila encodes a homo-Iogue of cyclosporin A-binding protein. Nature 338: 67-70.
32. Schneuwly, S., R. D. Shortridge, D. C. Larrivee, T. Ono, M. Ozaki, and W. L. Pak. 1989. Drosophila ninaA gene encodes an eye-specific cyclophilin (cyclosporine A binding protein). Proc. Natl. Acad. Sci. USA 86: 5390-5394.
33. Dwyer, N. D., E. R. Troemel, P. Sengupta, and C. I. Bargmann. 1998. Odorant receptor localization to olfactory cilia is mediated by ODR-4, a novel membrane-associated protein. Cell 93: 455-466.
34. Gimelbrant, A. A., S. L. Haley, and T. S. McClintock. 2001. Olfactory receptor trafficking involves conserved regulatory steps. J. Biol. Chem. 276: 7285-7290.
35. McLatchie, L. M., N. J. Fraser, M. J. Main, A. Wise, J. Brown, N. Thompson, R. Solan, M. G. Lee, and S. M. Foord. 1998. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-Iike receptor. Nature 393: 333-339.
36. Christopoulos, A., G. Christopoulos, M. Morfis, M. Udawela, M. Laburthe, A. Couvineau, K. Kuwasako, N. Tilakaratne, and P. M. Sexton. 2003. Novel receptor partners and function of receptor activity-modifying proteins. J. Biol. Chem. 278: 3293-3297